The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized pilot study assessing the safety and tolerability hyperthermic intraperitoneal chemotherapy (HIPEC) at completion of interval cytoreductive surgery or chemotherapy the day prior to interval cytoreductive surgery for patients with stage III/IV ovarian cancer undergoing neoadjuvant chemotherapy.
 
Floor Jenniskens Backes
Consulting or Advisory Role - Abbott Diagnostics (I); Agenus; Agenus; AstraZeneca; Clovis Oncology; CMR Institute; Eisai; GlaxoSmithKline; Immunogen; Merck; Myriad Genetics; natera (Inst)
Research Funding - Clovis Oncology (Inst); Eisai (Inst); Immunogen (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate (for writing a chapter)
 
Corinne Calo
No Relationships to Disclose
 
Laura Chambers
No Relationships to Disclose